ASCO 2013—treatment of metastatic melanoma: is it still a story of success?

ISSN： 1865-5041

Source： memo - Magazine of European Medical Oncology, Vol.6, Iss.4, 2013-12, pp. : 244-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Oblimersen in the treatment of metastatic melanoma

By Tarhini Ahmad A Kirkwood John M

Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. : 263-271

Future Medicine

Access to resources Recommend Favorite

Novel therapeutics for the treatment of metastatic melanoma

By Mansfield Aaron S Markovic Svetomir N

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 543-557

Future Medicine

Access to resources Recommend Favorite

Recent developments in the palliative treatment of breast cancer: ASCO 2013

By Petru Edgar Idris Tina Kolovetsiou Vassilliki Schest Eva

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 233-235

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

By Seeber A. Binder M. Steiner A. Wolff K. Pehamberger H.

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2129-2131

Elsevier

Access to resources Recommend Favorite

Current and Future Directions in the Treatment of Metastatic Malignant Melanoma

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 6, 2003-11 ,pp. : 393-398

Bentham Science Publishers

Access to resources Recommend Favorite